Impact of 18F-FDG-PET/CT on Clinical Management in Patients with Cholangiocellular Carcinoma.
Lena Sophie KieferJulia SeklerBrigitte GückelMareen Sarah KrausChristian la FougèreKonstantin NikolaouMichael BitzerSergios GatidisChristina PfannenbergPublished in: BJR open (2021)
Systematic implementation of 18F-FDG-PET/CT may enable a more appropriate and tailored treatment of patients with CCA, especially in cases of suspected recurrence.